Key Laboratory of Pathobiology, Department of Pathophysiology, Ministry of Education, College of Basic Medical Sciences, Jilin University, 126 Xinmin Street, Changchun 130021, China.
School of Medicine, Southern University of Science and Technology, Shenzhen 518000, China.
Int J Mol Sci. 2023 Oct 11;24(20):15066. doi: 10.3390/ijms242015066.
Ovarian cancer is the most lethal gynecologic malignancy, and metastasis is the major cause of death in patients with ovarian cancer, which is regulated by the coordinated interplay of genetic and epigenetic mechanisms. Histone deacetylases (HDACs) are enzymes that can catalyze the deacetylation of histone and some non-histone proteins and that are involved in the regulation of a variety of biological processes via the regulation of gene transcription and the functions of non-histone proteins such as transcription factors and enzymes. Aberrant expressions of HDACs are common in ovarian cancer. Many studies have found that HDACs are involved in regulating a variety of events associated with ovarian cancer metastasis, including cell migration, invasion, and the epithelial-mesenchymal transformation. Herein, we provide a brief overview of ovarian cancer metastasis and the dysregulated expression of HDACs in ovarian cancer. In addition, we discuss the roles of HDACs in the regulation of ovarian cancer metastasis. Finally, we discuss the development of compounds that target HDACs and highlight their importance in the future of ovarian cancer therapy.
卵巢癌是最致命的妇科恶性肿瘤,转移是卵巢癌患者死亡的主要原因,这是由遗传和表观遗传机制的协调相互作用调节的。组蛋白去乙酰化酶(HDACs)是可以催化组蛋白和一些非组蛋白蛋白去乙酰化的酶,通过调节基因转录和转录因子等非组蛋白蛋白的功能,参与多种生物过程的调节。HDACs 的异常表达在卵巢癌中很常见。许多研究发现,HDACs 参与调节与卵巢癌转移相关的多种事件,包括细胞迁移、侵袭和上皮-间充质转化。本文简要概述了卵巢癌转移以及 HDACs 在卵巢癌中的失调表达。此外,我们还讨论了 HDACs 在调节卵巢癌转移中的作用。最后,我们讨论了针对 HDAC 的化合物的开发,并强调了它们在卵巢癌治疗未来中的重要性。